ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Reneo Receives FDA Orphan Drug Designation for Primary Mitochondrial Myopathies Treatment
July 03, 2020Reneo Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) Office of Orphan Products Development has granted Orphan Drug Designation to the company's lead drug candidate, REN001, for the treatment of primary mitochondrial myopathies ... -
Reneo Pharmaceuticals Initiates Clinical Trial in McArdle Disease
March 09, 2020Reneo Pharmaceuticals has expanded its clinical development program for REN001, into glycogen storage disease type V (GSD V), also known as McArdle disease.
Pharma Sources Insight January 2025
